April 25, 2024
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics License Application (BLA) for prademagene zamikeracel (pz-cel), which is […]
April 25, 2024
Overall, cancer mortality in the United States has declined over the past few decades. But there are some exceptions. Deaths from endometrial cancer, for instance, have […]
April 25, 2024
An evolving legal landscape surrounding medication abortion has left physicians with as many questions as patients. A panel of clinicians at the American College of Physicians […]
April 25, 2024
COMMITTEE’S OFFICIAL DESIGNATION Pharmacy Compounding Advisory Committee AUTHORITY The Pharmacy Compounding Advisory Committee (the Committee) is required by section 503A and section 503B of the Federal […]
April 25, 2024
DENVER — When combined with rHuPh20, a recombinant DNA-derived human hyaluronidase, efgartigimod, promises a new treatment option for chronic inflammatory demyelinating polyneuropathy (CIDP) , according to […]
April 25, 2024
Planned cesarean delivery (CD) on maternal request (CDMR) is not associated with an increased risk for neonatal or infant infections compared with planned vaginal delivery (VD), […]
April 25, 2024
LONDON — A machine learning model designed to predict inpatient hypoglycemic events using only capillary blood glucose (CBG) showed excellent performance, according to results of an […]
April 25, 2024
Canada is unlikely to meet the World Health Organization’s (WHO’s) target of eliminating the hepatitis C virus (HCV) by 2030, research suggested. The elimination targets for […]
April 25, 2024
For patients with relapsed/refractory follicular lymphoma (R/R FL), chimeric antigen responder (CAR) T-cell therapy offers the best chance of survival, despite its high rate of serious […]